Spinning gyroscope, balancing on a red cable

Featured image by Yellow Dog Productions/Getty Images

2024 Wrapped

A rough year for Europe’s PE-backed IPOs gave just a handful of winners

Four out of the top 10 PE-backed IPOs in 2024 are trading below offer price.

Tough exits remained a main theme in European private equity in 2024, but the drought was especially acute in the IPO market.

While total European IPO value fell 25% to €64.1 billion (around $66.7 billion) this year, according to PitchBook data, the drop among PE-backed listings was steeper. Value fell 33% to €41.8 billion despite the total number of such IPOs more than doubling to 19 from nine the previous year.

Of the 10 largest PE-backed companies to list this year, four are trading below their offer price.

Galderma has shown the best performance—trading at 81% above its offer price, as of Dec. 18. The Switzerland-based skincare product maker, which was backed by the Abu Dhabi Investment Authority, Ardian and EQT, raised 2.28 billion Swiss francs (around $2.5 billion) when it listed on the SIX Swiss Exchange in March.

Planisware, a French B2B SaaS provider in the project management space, is also trading at 69% above its offer price, while London-based financial firm Marex Group and Luxembourg-based CVC Capital Partners are both maintaining a 50% gain.

On the other hand, German cosmetics and perfumery chain Douglas is trading in the red, down 24% from its listing price.

As noted in PitchBook’s Q3 2024 European PE Breakdown, the performance of the PE-backed companies is less impressive when considering that the wider STOXX Europe 600 Index is up 27.8% year to date.

Featured image by Yellow Dog Productions/Getty Images

Learn about our editorial standards.